Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid

Autor: Orazio Schillaci, Federica Scalorbi, Federico Caobelli, Giorgio Saladini, Manuela Vadrucci, Pierpaolo Alongi, Laura Evangelista, Agostino Chiaravalloti, Davide Donner
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Male
Oncology
endocrine system diseases
030218 nuclear medicine & medical imaging
0302 clinical medicine
Carcinoembryonic antigen
Recurrence
Positron Emission Tomography Computed Tomography
hemic and lymphatic diseases
18F-DOPA PET/CT
80 and over
Medullary thyroid carcinoma
Aged
80 and over
biology
Prognostic value
Restaging
Adult
Aged
Carcinoma
Neuroendocrine
Dihydroxyphenylalanine
Disease-Free Survival
Female
Humans
Middle Aged
Retrospective Studies
Thyroid Neoplasms
Thyroid
General Medicine
Neuroendocrine
medicine.anatomical_structure
Medullary carcinoma
030220 oncology & carcinogenesis
F-DOPA PET/CT
Radiology
medicine.medical_specialty
Medullary cavity
Malignancy
Thyroid carcinoma
03 medical and health sciences
Settore MED/36 - Diagnostica per Immagini e Radioterapia
Internal medicine
medicine
Radiology
Nuclear Medicine and imaging
In patient
PET-CT
business.industry
Carcinoma
medicine.disease
biology.protein
business
Popis: Medullary thyroid carcinoma (MTC) is a malignancy accounting for about 5-8% of thyroid cancers. Serum calcitonin and carcinoembryonic antigen (CEA) levels are widely used to monitor disease progression. However, prognostic factors able to predict outcomes are highly desirable. We, therefore, aimed to assess the prognostic role of60 patients (mean age 64 ± 13 years, range 44-82) with recurrent MTC were eligible from a multicenter database. All patients underwent a restaging
Databáze: OpenAIRE
Externí odkaz: